Consolidated Balance Sheets - USD ($) $ in Millions	Oct. 31, 2023	Oct. 31, 2022
Current assets:
Cash, cash equivalents and restricted cash	$ 3,232	$ 3,145
Accounts receivable, net of allowance for credit losses of $93 and $107, respectively	4,237	4,546
Inventory	6,862	7,614
Other current assets	3,646	4,431
Total current assets	17,977	19,736
Property, plant and equipment, net	2,827	2,774
Goodwill	8,591	8,541
Other non-current assets	7,609	7,443
Total assets	37,004	38,494
Current liabilities:
Notes payable and short-term borrowings	230	218
Accounts payable	14,046	15,303
Other current liabilities	10,212	10,668
Total current liabilities	24,488	26,189
Long-term debt	9,254	10,796
Other non-current liabilities	4,331	4,534
Commitments and contingencies
Stockholders’ deficit:
Preferred stock, $0.01 par value (300 shares authorized; none issued)	0	0
Common stock, $0.01 par value (9,600 shares authorized; 989 and 980 shares issued and outstanding at October 31, 2023, and 2022 respectively)	10	10
Additional paid-in capital	1,505	1,172
Accumulated deficit	(2,361)	(4,492)
Accumulated other comprehensive (loss) income	(223)	285
Total stockholders’ deficit	(1,069)	(3,025)
Total liabilities and stockholders’ deficit	$ 37,004	$ 38,494